Alflutop, 2 ml 5 pcs.

Pharmacotherapeutic group: tissue repair stimulator of natural origin

ATX code: M09AX

Pharmacological action

Alflutop is a chondroprotector, the active component of which is bioactive concentrate of small marine fish. The concentrate contains mucopolysaccharides (chondroitin sulfate), amino acids, peptides, ions of sodium, potassium, calcium, magnesium, iron, copper and zinc.

Alflutop prevents destruction of the macromolecular structures of normal tissues, stimulates repair processes in the interstitial tissue and articular cartilage tissue, which explains its analgesic effect.

The anti-inflammatory action and tissue regeneration are based on inhibition of hyaluronidase activity and normalization of hyaluronic acid biosynthesis.

These two effects are synergistic and have the effect of activating tissue repair processes (in particular the restoration of cartilage structure).

Indications

Composition

Composition of the drug per 1 ml:

The active ingredient:

Bioactive concentrate of small marine fish 0.1 ml;

Auxiliary substances:

phenol not more than 0.005 g,

water for injection up to 1 ml.

How to take, the dosage

In polyosteoarthritis and osteochondrosis the drug is administered deeply intramuscularly:

– 1 ml per day, the course of treatment is 20 injections (1 injection per day for 20 days)

or

– 2 ml every other day, the course of treatment is 10 injections (1 injection every other day for 20 days).

If large joints are affected predominantly, the drug is injected intraarticularly 1 to 2 ml into each joint at intervals of 3 to 4 days. A total of 5 to 6 injections into each joint for the course.

A combination of intraarticular and intramuscular methods of administration is possible.

The course of treatment is recommended to be repeated in 6 months after physician’s consultation.

Special Instructions

Impact on driving and operating machinery

The use of the drug does not affect the ability to perform potentially hazardous activities requiring increased concentration and speed of psychomotor reactions (driving vehicles, operating moving mechanisms, work of dispatcher and operator).

Synopsis

Contraindications

Hypersensitivity to the components of the drug.

Pregnancy and breast-feeding.

Children under 18 years of age (due to lack of clinical data in this category of patients).

Side effects

The side effects are grouped according to the WHO classification of the incidence of adverse reactions: very frequently (≥1/10), frequently (≥1/100 to <1/10), infrequently (≥1/1000 to <1/100), rarely (≥1/10000 to <1/1000), very rarely (<1/10000), frequency is unknown (frequency cannot be determined based on available data).

Rare: itchy dermatitis, reddening of the skin and burning sensation at the site of drug administration, transient myalgia. Very rare: development of anaphylactic reactions. Frequency unknown: with intra-articular injections a transient increase in pain syndrome is possible.

Overdose

Pregnancy use